- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AMRN
Recent news which mentions AMRN
Earnings Scheduled For March 1, 2022
March 01, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
51 Biggest Movers From Yesterday
January 26, 2022
From Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
January 25, 2022
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
January 25, 2022
From Benzinga
From InvestorPlace
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
From Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
From InvestorPlace
Cramer Shares His Thoughts On Dynavax, Nucor And Amarin
September 24, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
From Benzinga
7 Busted Biotech Stocks Due for a Rebound
September 08, 2021
From InvestorPlace
5 Stocks With 195% to 467% Upside, According to Wall Street
September 08, 2021
From Motley Fool
Atossa Therapeutics Has a Steep Climb Ahead of It
August 31, 2021
From InvestorPlace
Amarin Stock Moves Higher As Vascepa Cuts Risk Of Heart Attacks
August 23, 2021
Tickers
AMRN
From Benzinga
My 2019 Report Card: Up 319%
August 15, 2021
From Motley Fool
77 Biggest Movers From Yesterday
August 13, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.